Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company TaiwanJ Pharmaceuticals Co. Ltd.
DescriptionUndisclosed off-patent drug
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationHepatitis C virus (HCV)
Indication DetailsTreat liver damage in hepatitis C patients
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today